History
  • No items yet
midpage
Arbutus Biopharma Corporation v. Moderna, Inc.
1:22-cv-00252
| D. Del. | Aug 29, 2025
|
Check Treatment
|
Docket

*1 Case 1:22-cv-00252-JDW Document 560 Filed 08/29/25 Page 1 of 2 PageID #: 33906

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ARBUTUS BIOPHARMA CORPORATION )

and GENEVANT SCIENCES GmbH, )

) Plaintiffs, ) ) v. ) C.A. No. 22-252 (JDW)

) MODERNA, INC. and MODERNATX, INC. )

) Defendants. ) MODERNA, INC. and MODERNATX, INC., )

) Counterclaim-Plaintiffs, ) ) v. )

) ARBUTUS BIOPHARMA CORPORATION )

and GENEVANT SCIENCES GmbH, )

) Counterclaim-Defendants. ) [PROPOSED] ORDER AND NOW, this ____ day of _______________, 2025, upon consideration of Plaintiffs’ Motion to Exclude Certain Expert Testimony of Rutherford, Vellturo, and Prud’homme (D.I. 558 ), it is ORDERED that Plaintiffs’ Motion to Exclude Certain Expert Testimony of Rutherford, Vellturo, and Prud’homme is GRANTED:

1. Plaintiffs’ Motion to Exclude the testimony of Dr. Vellturo is GRANTED with respect

to Dr. Vellturo’s opinions relating to Medicare and Medicaid cost-savings, including Paragraphs 39-43 of Dr. Vellturo’s November 21, 2024 Opening Expert Report and Paragraphs 30-31 of Dr. Vellturo’s March 21, 2025 Reply Expert Report re 28 U.S.C. 1498;

Case 1:22-cv-00252-JDW Document 560 Filed 08/29/25 Page 2 of 2 PageID #: 33907

2. Plaintiffs’ Motion to Exclude the testimony of Dr. Prud’homme is GRANTED with

respect to certain of Dr. Prud’homme’s opinions relating to a supposed inability to measure infringement, including Paragraphs 128, 130-133, 135, 229-231, and 233 of his Opening Report, and Paragraphs 37, 46-47, 51-53, 57, 60-62, 89, 93, and 150-158 of his Reply Report.

3. [Alternatively, if Moderna's motion to exclude Brill and Pitts is granted: Plaintiffs’ Motion to Exclude the testimony of Dr. Rutherford and Dr. Vellturo is GRANTED with respect to Dr. Rutherford’s opinions in his November 21, 2024 Opening Expert Report and March 21, 2025 Reply Expert Report, and with respect to Dr. Vellturo’s opinions in his November 21, 2024 Opening Expert and March 21, 2025 Reply Expert Report re 28 U.S.C. 1498].

BY THE COURT: _____________________________ JOSHUA D. WOLSON, J. 2

Case Details

Case Name: Arbutus Biopharma Corporation v. Moderna, Inc.
Court Name: District Court, D. Delaware
Date Published: Aug 29, 2025
Docket Number: 1:22-cv-00252
Court Abbreviation: D. Del.
AI-generated responses must be verified and are not legal advice.
Your Notebook is empty. To add cases, bookmark them from your search, or select Add Cases to extract citations from a PDF or a block of text.